November 2004, Dean Baker

This study’s projections show that all states would see substantial savings under the Free Market Drug Act, a proposal to directly fund drug research and allow all new drugs to be sold as generics.  The biggest winners would be New York, California and Texas. Over the years 2009 to 2013, these states would save $9.3 billion, $7.1 billion, and $3.7 billion, respectively.

Report pdf_small

Press Release

Site Maintenance

"The CEPR website currently takes longer to load than usual. We hope to have this and other issues addressed shortly. While this much needed site maintenance is taking place, our content is still available so please continue to slooowwwly surf the pages of our site. Thank you for your patience."